Author(s):
Anushka Dubey, Koumudi Rao, Krishna Patel, Mital Patel, Jitendra Vaghasiya
Email(s):
anushka846932@gmail.com
DOI:
10.52711/2231-5659.2025.00016 
Address:
Anushka Dubey1*, Koumudi Rao1, Krishna Patel1, Mital Patel2, Jitendra Vaghasiya3
1,2Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat – 391760, India.
3Parul College of Pharmacy and Research, Parul University, Ahmedabad, Gujarat – 380058, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
An adverse drug reaction (ADRs) is a response to a drug which is noxious, unintended and which occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of disease or for the modification of physiologic function. They are one of the growing reasons of morbidity and mortality internationally, and could stay an enormous public health trouble, and represent a massive economic burden in terms of care prices, which contributes to a major proportion of hospital admissions. As per the findings from the Centre for Health Policy Research, the proportion of approved drugs in the U.S. associated with adverse reactions that go undetected during clinical trials is about 50%. Studies conducted in several parts of India have estimated the incidence of suspected ADRs to be nearly 2% to 3% among hospitalized patients. A recent systematic review estimated the median incidence of ADRs that led to hospitalization and those that developed during hospitalization as 2.85% and 6.34% respectively. According to several reports, ADR associated hospital admission is around 5% and almost 15-20% of patients admitted to hospital experience ADRs. Sometimes, ADR-related costs, such as hospitalization, surgery and lost productivity, exceed the cost of the medications. The study was conducted in a tertiary care hospital were 125 suspected ADRs were reported to the Pharmacovigilance department of the hospital and then forwarded to the regional ADR reporting center, and CDSCO.
Cite this article:
Anushka Dubey, Koumudi Rao, Krishna Patel, Mital Patel, Jitendra Vaghasiya. An Ambispective Study on Adverse Drug Reactions in a Tertiary Care Teaching Hospital. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(2):107-2. doi: 10.52711/2231-5659.2025.00016
Cite(Electronic):
Anushka Dubey, Koumudi Rao, Krishna Patel, Mital Patel, Jitendra Vaghasiya. An Ambispective Study on Adverse Drug Reactions in a Tertiary Care Teaching Hospital. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(2):107-2. doi: 10.52711/2231-5659.2025.00016 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-2-1
REFERENCE:
1. Manisha Dhondising Rajput, Y. B. Rajput, L. D. Rajput. A Review on Adverse Drug Reaction. Asian J. Pharm. Res. 2020; 10(3): 221-225.
2. Lakshyajeet Nath, Urmi Choudhury, Mangala Lahkar. A Study about the pattern of adverse effects of various oncology drugs in a Tertiary Care Hospital of North East India. Research Journal of Pharmacology and Pharmacodynamics.2022; 14(4):208-2.
3. Sumit Kumar, Badruddeen, S. P. Singh, Akhtar Juber, Mohammad Irfan Khan. Evaluation of Dermatological Adverse Drug Reactions in a Tertiary Care Hospital of Northern India. Research J. Pharm. and Tech. 2019; 12(7): 3517-3521.
4. S. S. Shuka, Bina Gidwani, R. Pandey, S. P. Rao, V. Singh, Amber Vyas. Importance of Pharmacovigilance in Indian Pharmaceutical Industry. Asian J. Res. Pharm. Sci. 2012; 2(1): 4-8.
5. Shraddha Anil Naik. Review on Pharmacovigilance. Asian J. Pharm. Res. 2020; 10(2):123-128.
6. Badar Uddin Umar, Mainul Haque. Adverse Drug Reactions in Bangladeshi Health Care Setup: An Update. Research J. Pharm. and Tech. 2015; 8(11): 1598-1602.
7. Sharma R, Kellarai A. Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospital. J Pharmacol Pharmacother. 2014; 5(4); 248-50
8. IUPHAR Pharmacology Education Project, Available from https://www.pharmacologyeducation.org/clinical pharmacology/adversedrugreactions#:~: text=An%20adverse%20drug%20reaction%20(ADR,discontinued%20or%20the%20dose%20reduced.
9. Patton K, Borshoff DC. Adverse Drug Reactions. Adverse drug reactions Anesthesia Wiley Online Library. 2018; 73(S1):76-84
10. Raj Purnima, Temburnikar Pankaj, Rathore M, Verma Vijay, Pandey SN. Antibiotics Induced Adverse Drug Reaction Monitoring in a Teaching Hospital in Chhattisgarh. Research J. Pharmacology and Pharmacodynamics. 2012; 4(1): 13-16.
11. Sundaran S, Ps A, Alex A, Krishnan A, Jacob at, Babu G, Balakrishnan S. Spontaneous Adverse Drug Reaction Reporting in a Tertiary Care Hospital in Calicut. Asian J Pharm Clin Res. 2018; 11(8): 283-5
12. Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists' attitudes on adverse drug reaction reporting. Drug Safety. 2006 Apr 1: 29(4): 331-40
13. S Lincy, M Greeshma, E Maheswari, S Tharanath, Subeesh Viswam. An Empirical Study to assess the Pattern and Predictors of Adverse Drug Reactions associated with Polypharmacy in the Department of General Medicine. Research J. Pharm. and Tech. 2018; 11(11): 5042-5048.
14. Life Expectancy in India (worldlifeexpectancy.com)
15. Coleman JJ, Pontefract SK. Adverse Drug Reactions. Clin Med (Lond). 2016; 16(5):481- 485.
16. Meda Venkatasubbaiah, P. Dwarakanadha Reddy & Suggala V. Satyanarayana. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital. Alexandria Journal of Medicine. 2018; 54(4): 597-603.
17. Dubrall, D., Just, K.S., Schmid, M. et al. Adverse drug reactions in older adults: a retrospective comparative analysis of spontaneous reports to the German Federal Institute for Drugs and Medical Devices. BMC Pharmacol Toxicol. 2020: 21
18. Hailye Birhane, Mojahidul Islam, Damen H/mariam, Vijender Singh. Pharmacovigilance: Adverse Drug Reactions (ADRs) in Pediatric patients in Ethiopia. Retrospective Study. Research J. Pharm. and Tech. 2021; 14(3):1499-1506.
19. Rayees N M, Sampath Kumar, Bharath Raj K C, Rajesh K S, Juno J Joel, Prasanna Shama K, Gururaja M P, Nandakumar U P. A Prospective Observational Study on Adverse Drug Reactions in General Medicine Department of a Tertiary Care Teaching Hospital. Research J. Pharm. and Tech. 2019; 12(5): 2289-2298.
20. Renata Rezende de Menezes, Maria das Dores Graciano Silva, Antônio Luiz Pinho Ribeiro, Marcelo Martins Pinto Filho, Gláucia Helena Martinho, Luna Elisabeth Carvalho Ferreira, Maria Auxiliadora Parreiras Martins, Causality assessment of adverse drug reactions by applying a global introspection method in a high complexity hospital. Exploratory Research in Clinical and Social Pharmacy. 2021; 3: 100064, https://doi.org/10.1016/j.rcsop.2021.100064.
21. Keche, Yogendra; Gaikwad, Nitin; Dhaneria, Suryaprakash. Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis. Journal of Family Medicine and Primary Care. 2021; 10(7): 2541-2545.
22. Rout, Anima and Panda, Rajendra and Mishra, Vedvyas and Parida, Prasant and Mohanty, Srikant. Pharmacovigilance in cancer chemotherapy in regional cancer center of Eastern India: prospective observational study. International Journal of Basic and Clinical Pharmacology. 2017; 10.18203/2319-2003.ijbcp20173148.
23. Patel BJ and Patel CR. Assessment of causality, severity and preventability of adverse drug reactions of cancer chemotherapy in a tertiary care teaching hospital, Gujarat, India. Int J Pharm Sci and Res. 2021; 12(7): 3950-58.
24. Fosnes GS, Lydersen S, Farup PG. Constipation and diarrhoea - common adverse drug reactions? A cross sectional study in the general population. BMC Clin Pharmacol. 2011; 11: 2.
25. Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalized children: international multicentre study. European Journal of Clinical Pharmacology. 2012; 68(5): 801-10.
26. Balamurugan Tangiisuran, Juliet Wright, Tischa Van der Cammen, Chakravarthi Rajkumar. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age and Ageing. 2009; 38(4): 358–35